Credit rating
Company information
About the company
HCC Pharm ApS (CVR number: 41029013) is a company from ASSENS. The company recorded a gross profit of 28.3 kDKK in 2023. The operating profit was 4.1 kDKK, while net earnings were -4.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 0.6 %, which can be considered weak but Return on Equity (ROE) was -0.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -14.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. HCC Pharm ApS's liquidity measured by quick ratio was 2.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Volume | ||||
Net sales | ||||
Gross profit | -63.45 | 18.38 | 29.02 | 28.33 |
EBIT | -87.65 | -5.82 | 4.81 | 4.13 |
Net earnings | -87.65 | -24.68 | -13.49 | -4.27 |
Shareholders equity total | -47.65 | -72.33 | -85.81 | -90.09 |
Balance sheet total (assets) | 559.39 | 535.19 | 555.89 | 550.13 |
Net debt | 582.50 | 22.75 | 610.08 | 610.22 |
Profitability | ||||
EBIT-% | ||||
ROA | -14.4 % | -1.0 % | 0.8 % | 0.6 % |
ROE | -15.7 % | -4.5 % | -2.5 % | -0.8 % |
ROI | -15.0 % | -1.0 % | 0.8 % | 0.7 % |
Economic value added (EVA) | -87.65 | -3.43 | 8.45 | 7.24 |
Solvency | ||||
Equity ratio | -7.8 % | -11.9 % | -13.4 % | -14.1 % |
Gearing | -1222.6 % | -31.5 % | -710.9 % | -677.4 % |
Relative net indebtedness % | ||||
Liquidity | ||||
Quick ratio | 1.4 | 2.1 | ||
Current ratio | 1.4 | 2.1 | ||
Cash and cash equivalents | ||||
Capital use efficiency | ||||
Trade debtors turnover (days) | ||||
Net working capital % | ||||
Credit risk | ||||
Credit rating | B | BB | BB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.